Colon-specific regulation of vitamin D hydroxylases—a possible approach for tumor prevention
Authors:
- Enikö KállayEnikö Kállay
- Giovanna BisesGBGiovanna Bises
- Erika BajnaEBErika Bajna
- Christian BieglmayerCBChristian Bieglmayer
- Waltraud GerdenitschWGWaltraud Gerdenitsch
- Ilse SteffanISIlse Steffan
- Shigeaki KatoSKShigeaki Kato
- H.James ArmbrechtHAH.James Armbrecht
- Heide S. CrossHCHeide S. Cross
Open Access
- 19 May 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 26 (9) , 1581-1589
Abstract
Epidemiological data suggest a protective role of calcium and vitamin D against colorectal tumor pathogenesis. 1,25-dihydroxyvitamin D 3 (1,25-D 3 ) is a key determinant of calcium homeostasis, cell proliferation and differentiation. Calcium in the intestinal lumen functions as a growth regulator and may prevent cancer by direct reduction of colonocyte proliferation. While calcium or vitamin D can counteract proliferation by itself, they could also interact if nutritional calcium were to modulate colonic vitamin D synthesis. In this paper we demonstrate that colonic and renal vitamin D hydroxylases are regulated independently. When mice were fed a modified AIN-76 diet containing low dietary calcium (0.1 or 0.04%) fecal calcium content was as low as 5% of that found in mice on a 0.9% calcium containing diet. Low fecal calcium concentration enhanced proliferating cell nuclear antigen expression in the colon mucosa and reduced that of the cyclin dependent kinase inhibitor p21. While low dietary calcium did not affect colonic expression of VDR or 25-hydroxyvitamin D 3 1α-hydroxylase (CYP27B1) mRNA, it influenced their renal expression in the expected manner by elevating the CYP27B1 expression and reducing VDR and 25-hydroxyvitamin D 3 24-hydroxylase (CYP24) expression. In contrast, low calcium diets significantly augmented colonic CYP24 mRNA expression, but only in the ascending colon. This might result in reduced colonic accumulation of 1,25-D 3 during hyperproliferation caused by low dietary calcium and might support site-specific tumorigenesis. The important realization that low dietary calcium by itself is a risk factor for colorectal carcinogenesis and that colonic and renal vitamin D hydroxylases indeed are regulated differently from each other will provide novel approaches for colon cancer prevention.Keywords
This publication has 45 references indexed in Scilit:
- Regulation of 25‐hydroxyvitamin D3‐24‐hydroxylase mRNA by 1,25‐dihydroxyvitamin D3 and parathyroid hormoneJournal of Cellular Biochemistry, 2003
- Vitamin D: A millenium perspectiveJournal of Cellular Biochemistry, 2003
- Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signalingJournal of Cell Biology, 2001
- 25-Hydroxy-Vitamin D Metabolism in Human Colon Cancer Cells during Tumor ProgressionBiochemical and Biophysical Research Communications, 2001
- Metabolism of Vitamin D3 by Human CYP27A1Biochemical and Biophysical Research Communications, 2000
- Transcriptional Regulation of the p21(WAF1/CIP1)GeneExperimental Cell Research, 1999
- Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: Expression of 25-hydroxyvitamin D3-1α-hydroxylase activity and regulation of sidechain metabolismThe Journal of Steroid Biochemistry and Molecular Biology, 1997
- Comparative in vivo expression of the calcitriol-24-hydroxylase gene in kidney and intestineJournal of Molecular Endocrinology, 1997
- Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: Response to calcium, vitamin D3 and calcitriol administration in vivoJournal of Bone and Mineral Research, 1995
- SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDYThe Lancet, 1989